Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Author(s) -
Matthew P. Deek,
Kim Van der Eecken,
Philip Sutera,
Rebecca A. Deek,
Valérie Fonteyne,
Adrianna A. Mendes,
Karel Decaestecker,
Ana P. Kiess,
Nicolaas Lumen,
Ryan Phillips,
Aurélie De Bruycker,
Mark V. Mishra,
Zaker Rana,
Jason K. Molitoris,
Bieke Lambert,
Louke Delrue,
Hailun Wang,
Kathryn Lowe,
Sofie Verbeke,
Jo Van Dorpe,
Renée Bultijnck,
Geert Villeirs,
Kathia De Man,
Filip Ameye,
Daniel Y. Song,
Theodore L. DeWeese,
Channing J. Paller,
Felix Y. Feng,
Alexander W. Wyatt,
Kenneth J. Pienta,
Maximillian Diehn,
Søren M. Bentzen,
Steven Joniau,
Friedl Vanhaverbeke,
Gert De Meerleer,
Emmanuel S. Antonarakis,
Tamara L. Lotan,
Alejandro Berlín,
Shankar Siva,
Piet Ost,
Phuoc T. Tran
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.22.00644
Subject(s) - medicine , hazard ratio , oncology , prostate cancer , clinical endpoint , cancer , clinical trial , confidence interval
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom